44 related articles for article (PubMed ID: 26765473)
1. Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis.
Zhao Y; Deng Y; Jiang Y; Zheng W; Tan Y; Yang Z; Wang Z; Xu F; Cheng Z; Yuan L; Peng H
Front Immunol; 2023; 14():1127599. PubMed ID: 36969238
[TBL] [Abstract][Full Text] [Related]
2. Histiocytic sarcoma following combination chemotherapy for primary mediastinal germ cell tumor: a diagnostic dilemma.
Yaegashi H; Kato Y; Nohara T; Izumi K; Kadono Y; Miyagi T; Nakashima T; Yoshimura K; Sato Y; Harada K; Mizokami A
Int Cancer Conf J; 2021 Apr; 10(2):144-148. PubMed ID: 33786289
[TBL] [Abstract][Full Text] [Related]
3. Three distinct hematological malignancies from a single germ cell tumor: a case report.
Spencer Chapman M; May PC; Olavarria E; Nadal Melsio E
J Med Case Rep; 2020 Nov; 14(1):222. PubMed ID: 33198808
[TBL] [Abstract][Full Text] [Related]
4. Unusual Presentation of a Rare Tumor: Histiocytic Sarcoma Presenting as a Finger Growth.
Ali Z; Hanif F
Cureus; 2019 Nov; 11(11):e6150. PubMed ID: 31890359
[TBL] [Abstract][Full Text] [Related]
5. [The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].
Adam Z; Pour L; Krejčí M; Zahradová L; Szturz P; Koukalová R; Rehák Z; Nebeský T; Hájek R; Král Z; Mayer J
Vnitr Lek; 2012 Nov; 58(11):856-66. PubMed ID: 23256832
[TBL] [Abstract][Full Text] [Related]
6. Mediastinal Germ Cell Tumor-associated Histiocytic Proliferations Treated With Thalidomide Plus Chemotherapy Followed by Alemtuzumab-containing Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation: A Case Report.
Fang LH; Shih LS; Lee PI; Chen WT; Chen RL
Medicine (Baltimore); 2016 Jan; 95(2):e2515. PubMed ID: 26765473
[TBL] [Abstract][Full Text] [Related]
7. Malignant histiocytoses/disseminated histiocytic sarcoma with hemophagocytic syndrome in a patient with mediastinal germ cell tumor.
Shinoda H; Yoshida A; Teruya-Feldstein J
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):338-44. PubMed ID: 18987551
[TBL] [Abstract][Full Text] [Related]
8. Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Pérez-Simón JA; Kottaridis PD; Martino R; Craddock C; Caballero D; Chopra R; García-Conde J; Milligan DW; Schey S; Urbano-Ispizua A; Parker A; Leon A; Yong K; Sureda A; Hunter A; Sierra J; Goldstone AH; Linch DC; San Miguel JF; Mackinnon S;
Blood; 2002 Nov; 100(9):3121-7. PubMed ID: 12384408
[TBL] [Abstract][Full Text] [Related]
9. Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.
Strout MP; Seropian S; Berliner N
Nat Rev Clin Oncol; 2010 Jul; 7(7):415-20. PubMed ID: 20404855
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide therapy for aggressive histiocytic lesions in the pediatric population.
Bailey KM; Castle VP; Hummel JM; Piert M; Moyer J; McAllister-Lucas LM
J Pediatr Hematol Oncol; 2012 Aug; 34(6):480-3. PubMed ID: 22810753
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab.
Shukla N; Kobos R; Renaud T; Teruya-Feldstein J; Price A; McAllister-Lucas L; Steinherz P
Cancer; 2012 Aug; 118(15):3719-24. PubMed ID: 22170006
[TBL] [Abstract][Full Text] [Related]
12. Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.
Gergis U; Dax H; Ritchie E; Marcus R; Wissa U; Orazi A
J Clin Oncol; 2011 Apr; 29(10):e251-3. PubMed ID: 21220616
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
